A new therapy is showing promise for patients living with the autoimmune condition, rheumatoid arthritis. Dawn Steiner said ...

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that primarily affects joints. The disorder is ...

This review discusses the features of oligoarticular, polyarticular, systemic, and psoriatic JIA and enthesitis-related ...

If you are not familiar with the term “Inflammaging,” you should be. Inflammaging refers to the chronic, low-grade, systemic ...

Objective To comprehensively assess multimorbidity burden in patients with rheumatoid arthritis (RA) in order to unify the multimorbidity definition for RA research and clinical practice.Methods In ...

It is evident that the morning symptoms of rheumatoid arthritis (RA) are linked to the circadian abnormal increase in night inflammation, favoured by inadequate cortisol secretion under conditions of ...

Abstract and Introduction Abstract Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events.

Objective: To assess the efficacy and safety of vaccination against influenza virus in patients with rheumatoid arthritis, with special emphasis on the effect of disease modifying antirheumatic drugs ...

Rheumatoid arthritis affects around one in 50 people in the UK, with gouty arthritis affecting one in 200. Drugs currently on the market can cause infrequent but severe side effects. The inflammation ...

Abstract Monoclonal antibodies are a group of complex and effective biologic agents used in the treatment of rheumatoid arthritis and other immune-mediated inflammatory diseases.